2004 Uses in Stock Options Clause

Stock Options from Employment Agreement

We are pleased to extend you this offer of employment with Carbylan Therapeutics, Inc. (the Company), contingent upon the conditions outlined in Section 8 below. This letter (the Agreement) contains the terms of our employment offer.

Stock Options. In connection with the commencement of your employment, the Company will recommend that the Companys Board of Directors grant you an option to purchase 274,317 shares of the Companys Common Stock (Option Shares) with an exercise price equal to the fair market value on the date of the grant. One quarter (12/48) of these option shares will vest on the 12-month anniversary of your Vesting Commencement Date (as defined in your Stock Option Agreement, which date will be your Start Date, as defined above) and the remaining Option Shares will vest one-forty-eighth (1/48) per month thereafter until all such remaining Option Shares have become fully vested (approximately four years from your Start Date). Vesting will, of course, depend on your continued employment with the Company. The option will be subject to the terms of the Companys 2004 Stock Plan and a stock option agreement between you and the Company in the form reasonably determined by the Company.

Stock Options from Employment Agreement

We are pleased to extend you this offer of employment with Carbylan Therapeutics, Inc. (the Company), contingent upon the conditions outlined in Section 8 below. This letter (the Agreement) contains the terms of our employment offer.

Stock Options. In connection with the commencement of your employment, the Company will recommend that the Companys Board of Directors grant you an option to purchase 422,026 shares of the Companys Common Stock (Option Shares) with an exercise price equal to the fair market value on the date of the grant. One quarter (12/48) of these option shares will vest on the 12-month anniversary of your Vesting Commencement Date (as defined in your Stock Option Agreement, which date will be your Start Date, as defined above) and the remaining Option Shares will vest one-forty-eighth (1/48) per month thereafter until all such remaining Option Shares have become fully vested (approximately four years from your Start Date). Vesting will, of course, depend on your continued employment with the Company. The option will be subject to the terms of the Companys 2004 Stock Plan and a stock option agreement between you and the Company in the form reasonably determined by the Company.

Stock Options from Employment Agreement

We are pleased to extend you this offer of employment with Carbylan Therapeutics, Inc. (the Company), contingent upon the conditions outlined in Section 8 below. This letter (the Agreement) contains the terms of our employment offer.

Stock Options. In connection with the commencement of your employment, the Company will recommend that the Companys Board of Directors grant you an option to purchase 274,317 shares of the Companys Common Stock (Option Shares) with an exercise price equal to the fair market value on the date of the grant. One quarter (12/48) of these option shares will vest on the 12-month anniversary of your Vesting Commencement Date (as defined in your Stock Option Agreement, which date will be your Start Date, as defined above) and the remaining Option Shares will vest one-forty-eighth (1/48) per month thereafter until all such remaining Option Shares have become fully vested (approximately four years from your Start Date). Vesting will, of course, depend on your continued employment with the Company. The option will be subject to the terms of the Companys 2004 Stock Plan and a stock option agreement between you and the Company in the form reasonably determined by the Company.

Stock Options from Employment Agreement

We are pleased to extend you this offer of employment with Carbylan Therapeutics, Inc. (the Company), contingent upon the conditions outlined in Section 8 below. This letter (the Agreement) contains the terms of our employment offer.

Stock Options. In connection with the commencement of your employment, the Company will recommend that the Companys Board of Directors grant you an option to purchase 422,026 shares of the Companys Common Stock (Option Shares) with an exercise price equal to the fair market value on the date of the grant. One quarter (12/48) of these option shares will vest on the 12-month anniversary of your Vesting Commencement Date (as defined in your Stock Option Agreement, which date will be your Start Date, as defined above) and the remaining Option Shares will vest one-forty-eighth (1/48) per month thereafter until all such remaining Option Shares have become fully vested (approximately four years from your Start Date). Vesting will, of course, depend on your continued employment with the Company. The option will be subject to the terms of the Companys 2004 Stock Plan and a stock option agreement between you and the Company in the form reasonably determined by the Company.

Stock Options from Employment Agreement

We are pleased to extend you this offer of employment with Carbylan Therapeutics, Inc. (the Company), contingent upon the conditions outlined in Section 8 below. This letter (the Agreement) contains the terms of our employment offer.

Stock Options. In connection with the commencement of your employment, the Company will recommend that the Companys Board of Directors grant you an option to purchase 274,317 shares of the Companys Common Stock (Option Shares) with an exercise price equal to the fair market value on the date of the grant. One quarter (12/48) of these option shares will vest on the 12-month anniversary of your Vesting Commencement Date (as defined in your Stock Option Agreement, which date will be your Start Date, as defined above) and the remaining Option Shares will vest one-forty-eighth (1/48) per month thereafter until all such remaining Option Shares have become fully vested (approximately four years from your Start Date). Vesting will, of course, depend on your continued employment with the Company. The option will be subject to the terms of the Companys 2004 Stock Plan and a stock option agreement between you and the Company in the form reasonably determined by the Company.

Stock Options from Separation Agreement and Release

This letter proposes an agreement (the Agreement) between you and the Company. The purpose of this Agreement is to establish an amicable arrangement for ending your employment relationship, including releasing the Company and related persons or entities from any claims and permitting you to receive separation pay and related benefits.

Stock Options. The Company has granted you under its 2004 Equity Incentive Plan (as originally adopted and as has been or may be amended, restated, modified or supplemented in accordance with its terms, the Equity Plan) options to purchase an aggregate of 434,760 shares of its common stock and restricted stock units covering 43,140 shares of its common stock (collectively, the Equity Awards, and each, an Equity Award). You acknowledge and agree that: (a) your service to the Company will end on the Separation Date; (b) each Equity Award will cease vesting as of the Separation Date; (c) each Equity Award will terminate following the Separation Date in accordance with the Equity Plan (including the provisions of Section 9.4(a) of the Equity Plan regarding exercise of stock options under the Equity Plan after the Separation Date); and (d) other than the outstanding Equity Awards or any shares of the Companys common stock you hold, you have no stock rights in the Company.

Stock Options from Employment Agreement

THIS EMPLOYMENT AGREEMENT (the Agreement), dated as of December 19, 2011 (the Effective Date), is by and between IASIS Healthcare Corporation, a Delaware corporation (the Company), and Frank A. Coyle (the Executive).

Stock Options. During the Term, the Executive shall be eligible to participate in the 2004 Stock Option Plan or other equity plans established by the Board for the Companys senior executive officers, as the same may be amended from time to time.

Stock Options

I am pleased to offer you an employment position with GCT Semiconductor, Inc. (the Company or GCT) pursuant to the following terms and conditions:

Stock Options. In further consideration for your services, but subject to the approval of the Board of Directors of the Company; you will be granted options to purchase Six Hundred Fifty Thousand (650,000) shares of the Companys common stock pursuant to the terms and conditions of the Companys 1999 or 2002 Stock Plan. A stock option agreement will be entered into between you and the Company, accordingly, within a reasonable time period after the commencement of your employment. The option exercise price will be equivalent to the fair market value of the shares at the date grant as determined by the Board of Directors of the Company. The options will vest over 4 years from the date of grant. In addition to the cash bonus discussed in the Section 3, an additional One Hundred Fifty Thousand (150,000) shares of stock options will be granted to you provided the Company maintains cash positive status and reaches net income of Five Million Dollars (5,000,000) during the fiscal year of 2004 subject to the approval of the Board of Directors. Pending the board approval, the half of One Hundred Fifty Thousand (150,000) shares will be fully vested upon the grant and the remaining is to be vested over 2 years. This will be also subject to the approval of the Board of Directors of the Company.

Stock Options

Stock Options. Stock Options granted under the SEEIP will be nonqualified stock options, granted with an exercise price at the market value of AngioDynamics Common Stock on the date of grant, have a 7 year term, and vest in equal parts over a 4 year period at the rate of 25% per year beginning on the first anniversary date following the date of grant. Stock Options are granted under and governed by to the terms of the 2004 Stock And Incentive Award Plan (As Amended).

Stock Options

Stock Options. Stock Options granted under the SEEIP will be nonqualified stock options, granted with an exercise price at the market value of AngioDynamics Common Stock on the date of grant, have a 7 year term, and vest in equal parts over a 4 year period at the rate of 25% per year beginning on the first anniversary date following the date of grant. Stock Options are granted under and governed by to the terms of the 2004 Stock And Incentive Award Plan (As Amended).